Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,472,096
-
Share change
-
+726,297
-
Total reported value
-
$4,111,281,844
-
Put/Call ratio
-
46%
-
Price per share
-
$329.79
-
Number of holders
-
169
-
Value change
-
+$498,327,735
-
Number of buys
-
121
-
Number of sells
-
55
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q1 2014
As of 31 Mar 2014,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,472,096 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, JENNISON ASSOCIATES LLC, Capital World Investors, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Viking Global Investors LP, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., and BlackRock Fund Advisors.
This page lists
169
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.